ArticleReproductive biology and endocrinology : RB&E2026
Identifying cycle-specific predictive factors for clinical pregnancy after recurrent implantation failure: a retrospective cohort study.
Article in Reproductive biology and endocrinology : RB&E, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveTo investigate whether the clinical predictors of achieving a clinical pregnancy differ between fresh and frozen embryo transfer cycles in patients with recurrent implantation failure (RIF) undergoing their first ART treatment after diagnosis.
methodsThis retrospective study reviewed 24,070 ART cycles performed at Peking University Third Hospital from 2021 to 2023 among patients with at least two documented embryo transfer cycles. Patients diagnosed with RIF were identified, and the first transfer cycle following diagnosis was assessed. After applying strict inclusion and exclusion criteria, 377 fresh and 922 frozen cycles were included. Clinical, hormonal, endometrial, and procedural characteristics were collected. Clinical pregnancy was defined as the primary outcome. Predictive factors were evaluated using univariate and multivariate logistic regression models.
resultsIndependent predictors of clinical pregnancy included younger age (OR = 0.939, 95% CI: 0.912–0.967, p < 0.001), higher AMH levels (OR = 1.045, 95% CI: 1.002–1.089, p = 0.039), elevated androgen (OR = 1.031, 95% CI: 1.004–1.059, p = 0.026), lower FSH (OR = 0.955, 95% CI: 0.913–0.998, p = 0.040), and greater endometrial thickness (OR = 1.057, 95% CI: 1.013–1.103, p = 0.011). The predictive factors differed between cycle types. In fresh cycles, the number of transferable embryos and the use of long or ultra-long stimulation protocols were additional significant predictors. In frozen cycles, only age, AMH, and endometrial thickness remained significant.
conclusionPredictors of clinical pregnancy in RIF patients differ between fresh and frozen embryo transfer cycles. Younger maternal age, favorable ovarian reserve (reflected by higher AMH and lower FSH), elevated androgen, and greater endometrial thickness are overall associated with higher pregnancy likelihood. Embryo availability and stimulation protocol further influence outcomes in fresh cycles, whereas frozen cycles exhibit a more limited predictor profile focused on patient ovarian reserve and endometrial conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.